In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival and overall (OS)?

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival and overall (OS)?

In what types of solid tumors has mutation-directed therapy been shown to improve patient outcomes, including progression-free survival and overall (OS)?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Professor Nong Xu, MD

Professor Nong Xu, MD

Department of Medical Oncology
The First Affiliated Hospital, School of Medicine
Zhejiang University
Hangzhou, China